Vice President, Immunology Scientific Innovation
Why I'm a JPAL
I am motivated by improving the lives of people living with debilitating diseases and believe that it must be a community effort. I am happy to contribute my expertise if helpful, and enjoy learning from the entrepenerial scientists of JLabs.
"As Vice President of Immunology Scientific Innovation at the Johnson & Johnson California Innovation Center, Jackie is responsible for creating and implementing an external innovation plan focused on developing an industry-leading portfolio of Immunology investment opportunities. This work will help solidify Janssen as the partner of choice in a highly competitive landscape, and identify and deliver the best opportunities for value-generating collaborations supporting our Immunology scientific strategy.
In her previous role, Jackie launched and led the Estrela Venture, Janssen Incubator, leading Janssen R&D efforts in discovering and developing innovative treatments for systemic lupus erythematosus (SLE). Estrela declared two new molecular entities, one of which is currently being studied in SLE patients. Jackie joined the Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Research Scientist in 2001, playing an instrumental role in the research and discovery of several flagship programs, including STELARA® (ustekinumab), for which she earned a Johnson Medal, and TREMFYA® (guselkumab). She received her B.S. in Biology from The Ohio State University, followed by her Ph.D. in Immunology from the College of Medicine at The Ohio State University, and was awarded a National Multiple Sclerosis Society postdoctoral fellowship at Stanford University School of Medicine."
Live each day!
Jackie is an avid fan of THE Ohio State University Buckeyes